
Europe's Quiet Digital Health Revolution: 6 Experts' Views
The digital health market in Europe is expected to exceed US$ 260 billion by 2030. A compound annual ... More growth rate of 22.7% is expected of Europe digital health market from 2025 to 2030.
Digital health is evolving rapidly across Europe. What's exciting you most right now?
Tobias Silberzahn, Senior Fellow for BSt Gesundheit:
'Digitally-enabled chronic disease management (especially for diabetes, obesity, mental health, and cardiovascular disease). These diseases cause 90% of deaths and 80% of healthcare costs in Europe. The WHO just published a European digital health action plan with strong language on chronic care and promising case studies. The momentum is finally building.'
Aditi U. Joshi, CEO; Author, Telehealth Success:
'What excites me most about digital health in Europe is the drive to build in collaboration with multiple stakeholders. The funding for large digital initiatives is in place and helps provide infrastructure to start the journey. At the same time, newer companies are also able to address these same problems in a more agile and iterative manner. The combination of both approaches is rare and may produce long-term success.'
Dr. Patrick Pfeffer, Managing Partner at Aescuvest:
'What excites me most is how AI is transforming diagnosis, clinical workflows, and decision support—and how the investment landscape is increasingly supporting these innovations.'
Fredrik Debong, Founder & Partner, 1921.vc:
'The biggest near-term impact will come from applying AI where data density and clinical relevance already intersect. Diabetes is the clearest example: continuous glucose, insulin, and behavioral data make it a live testbed for algorithmic breakthroughs, and costs to build have dropped by an order of magnitude in just a few years. Execution speed now decides winners. Founders can increasingly pick their investors—choose those who live and breathe these complex systems. In chronic care, deep domain focus isn't optional; it's the difference between building another app and reshaping how millions manage their health.'
Gabrielle Powell, Digital Health Advisor & Entrepreneur:
'Europe's established primary care infrastructure, combined with its commitment to data privacy and patient rights, is laying the groundwork for truly patient-centered digital solutions.'
Matteo Berlucci, CEO & CoFounder, Healthily:
'There is growing recognition that new digitally-enabled operating models for care delivery, especially for primary and chronic care, will be the way forward for health systems in Europe. This is creating space for new ecosystem collaborations across providers, pharma, tech, and public and private payors.'The recent HLTH Europe and HIMSS conferences generated buzz especially around digital health. What stood out?
Aditi U. Joshi:
'The two conferences had very different focuses—HLTH was more industry- and investor-facing, while HIMSS dove deep into provider systems. Together, they painted a fuller picture of where Europe is heading. The excitement around value-based care and population health is present at both, and it's interesting to see the maturity of organizations and health systems ready to take on new delivery models.'
Dr. Patrick Pfeffer:
'What stood out most was how AI and health data governance dominated discussions. It's clear these aren't just tech trends—they're becoming core to health system reform.'
Fredrik Debong:
'I finally see the pieces we've been speaking about for years come together. It's becoming real.'
Gabrielle Powell:
'The focus on an ecosystem view of healthcare stood out. There's increasing recognition that collaboration across sectors and geographies is essential for meaningful innovation.'
Matteo Berlucci:
'Europe is not 'behind'—it is just on a different trajectory, shaped by the unique mix of public systems and local contexts. The conferences demonstrated how important it is for European stakeholders to chart their own path, even while learning from others. And there's a fresh sense of urgency to address clinician burnout, patient access, and population health—especially as chronic disease rises.'Where do you see the biggest opportunities for impact in digital health in Europe in the next 12–18 months?
Tobias Silberzahn:
'Digitally-enabled chronic disease management (especially for diabetes, obesity, mental health, and cardiovascular disease). This is where the highest costs and worst outcomes are—and where digital has most potential to help.'
Aditi U. Joshi:
'I have seen that there is an opportunity to scale virtual care programs across regions, in areas that may not have had traditional services. Virtual programs that are proactive, inclusive, and designed with usability in mind have the best chance for success.'
Dr. Patrick Pfeffer:
'Over the next 12–18 months, I see the greatest impact in digital therapeutics and AI-enabled mental health tools. These can deliver measurable outcomes at scale, especially in underserved populations.'
Fredrik Debong:
'A swiftly dawning realisation of need among policymakers and payors—that if we do not act now, we will fall behind. This opens the door for accelerated action and adoption.'
Gabrielle Powell:
'The scaling of AI scribes from pilot programmes to real-world implementation will free up clinicians and improve documentation quality—arguably the biggest bottleneck today.'
Matteo Berlucci:
'The most immediate opportunity is to integrate virtual and hybrid care models into mainstream health systems, especially to manage chronic conditions and mental health. We are seeing interest from both governments and private insurers—but execution is everything.'What barriers still hold the digital health sector back—and how can they be overcome?
Tobias Silberzahn:
'Reimbursement codes are often lacking (e.g., for digital therapeutics), which prevents scaling. We need systemic changes to make innovation financially viable for providers.'
Aditi U. Joshi:
'Digital health faces barriers from fragmented systems and regulatory hurdles. But aligning incentives for all players—providers, payors, and patients—can accelerate adoption.'
Dr. Patrick Pfeffer:
'Two key barriers remain: societal acceptance and reimbursement. Overcoming these will require sustained education and clearer outcome-based payment models.'
Fredrik Debong:
'Still disparate regulations between countries, still lack of harmonisation. Also, not enough focus on the how of adoption—not just what tech should be used, but how it fits into existing care and economic systems.'
Gabrielle Powell:
'The primary barrier to the scaling of digital health solutions in Europe is the challenge of implementation. Even with great tools and willing users, systems are not designed for agile experimentation or rapid scaling. That needs to change.'
Matteo Berlucci:
'Too many pilots, not enough procurement. Innovation often stalls because health systems struggle to fund or operationalize new models beyond the pilot stage. Stronger public-private partnerships and more flexible reimbursement pathways could help.'How is Europe approaching responsible AI in healthcare compared to other regions?
Aditi U. Joshi:
'Europe leads with a strong focus on ethics and transparency. This helps build trust, which is critical to widespread AI adoption in healthcare.'
Dr. Patrick Pfeffer:
'Europe may not be the fastest adopter of AI in healthcare, but it is arguably the most principled. The EU AI Act is an important step in ensuring responsible deployment of these technologies.'
Fredrik Debong:
'High level and ethically, far better than elsewhere. But practically, we still lag in implementation. There's a gap between principle and practice.'
Gabrielle Powell:
'From a regulatory perspective, Europe leads globally. The EU AI Act sets a precedent for ensuring transparency, accountability, and fairness in health applications.'
Matteo Berlucci:
'Europe's approach emphasizes trust, equity, and long-term societal impact—which is commendable. The challenge now is to balance this with speed and scalability.'Final thoughts: What will success look like for European digital health in the near future?
Tobias Silberzahn:
'- Establishing reimbursement categories for patient-centered, tech-enabled chronic disease management
– Embedding new digital workflows for primary and chronic care into care teams
– Expanding new roles (e.g., digital care navigators) to support both patients and clinicians
– Training and upskilling 100,000s of clinicians and nurses in digital tools
– Keeping patients at the center'
Aditi U. Joshi:
'The dream is efficient, quality care powered by tech—but without losing the human connection. That balance will define success.'
Dr. Patrick Pfeffer:
'Success will mean nothing less than a redefinition of care delivery—more predictive, more participatory, and more personalized.'
Fredrik Debong:
'I assume that this is about local deployment, sustainability, and measurable change—not hype, not the 'next cool thing.''
Gabrielle Powell:
'Success in digital health will come as much from governance, education, and implementation science as from the technologies themselves.'
Matteo Berlucci:
'Success will mean that digital tools are no longer seen as 'add-ons' but as core to how we deliver care—equitably, efficiently, and compassionately.'Europe's digital health future won't be defined by any single technology or country—it will be shaped by systems that prioritize equity, usability, and impact. The experts in this roundtable are aligned on one thing: while Europe's approach may be slower and more fragmented, it also has the potential to build something more enduring, ethical, and human-centered. Now is the moment to move from pilots to platforms—and from promise to practice.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Weight loss drugs could soon be used to treat these seven other health conditions
Blockbuster diabetes and weight loss drugs from Eli Lilly and Novo Nordisk - including Mounjaro, Zepbound, Ozempic and Wegovy - generated over U$40 billion in combined sales last year. However, Novo Nordisk has warned that the rise in copycat versions of its weight-loss drug in the U.S. and competition from Lilly across several markets is expected to hurt Wegovy sales this year. Both companies are actively exploring other medical uses for these GLP-1 drugs, aiming to broaden their market reach and secure wider health insurance coverage, a strategy that has already seen some success. Here are some of the other conditions the drugs are being used and tested for: Alcohol addiction A study conducted by the University of Copenhagen's Psychiatric Centre Rigshospitalet, is investigating whether semaglutide - the main ingredient in Wegovy and Ozempic - can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity. Alzheimer's disease Novo Nordisk is testing semaglutide in a late-stage trial in patients with early Alzheimer's disease. The study, which will enrol 1,840 patients, could have an initial data readout as early as later this year. Cardiovascular disease Eli Lilly was testing tirzepatide - the main ingredient in Mounjaro and Zepbound - for patients with heart failure and obesity. Lilly had said it would enrol about 700 people in the study, but the company said in May that it had withdrawn its U.S. application for heart failure approval. The European Medicines Agency backed the use of Novo's semaglutide to help ease heart failure symptoms in people with obesity in September 2024. Chronic kidney disease Novo's Ozempic is approved in the United States for reducing the risk of kidney failure and disease progression, as well as the risk of death due to heart problems in diabetes patients with chronic kidney disease. Lilly's tirzepatide is being evaluated in a mid-stage study of patients with chronic kidney disease and obesity. Lilly plans to enrol up to 140 participants with the study expected to be completed next year. Liver disease Novo is testing semaglutide in a late-stage trial of patients with a common, but difficult to treat, type of fatty liver disease called non-alcoholic steatohepatitis, or NASH. The study is expected to be completed in April 2029 and include about 1,200 patients. Lilly's tirzepatide helped up to 74 per cent of patients achieve absence of the disease with no worsening of liver scarring at 52 weeks, compared with 13 per cent of patients on placebo, in a mid-stage trial for NASH, which is also now referred to as metabolic dysfunction-associated steatohepatitis, or MASH. Neurological disorders Researchers at the Danish Headache Centre are testing semaglutide along with a very low-calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises. The study has enrolled about 50 patients and is expected to be completed in October 2025. Sleep apnea Zepbound was approved by the U.S. Food and Drug Administration for obstructive sleep apnea in December 2024, making it the first drug to directly treat patients with the common disorder that causes breathing disruption while sleeping.
Yahoo
32 minutes ago
- Yahoo
FDA approves SetPoint's neuroimmune modulation device for RA treatment
The US Food and Drug Administration (FDA) has approved SetPoint Medical's implantable neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis (RA) in adults. The system is designed for individuals who are inadequately managed by or intolerant to current RA therapies such as biological and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs). The system is said to activate the body's natural anti-inflammatory and immune-restorative pathways by delivering electrical stimulation to the vagus nerve once a day. The neurostimulation therapy can potentially provide an alternative treatment without immune-compromising risks. The FDA approval was based on the outcomes of the RESET-RA study, a 242-patient double-blind, randomised, sham-controlled trial, which showed the system's efficacy and safety in this patient group. Patients tolerated the device placement procedure and the stimulation therapy well, with a low incidence of related serious adverse events at 1.7%. SetPoint Medical CEO Murthy Simhambhatla said: 'The approval of the SetPoint System, the first-in-class neuroimmune modulation platform, represents a transformative milestone in the management of autoimmune diseases. 'We are committed to improving the health of people living with RA, and look forward to working with providers and payers to make our innovative therapy accessible to their patients. We plan to introduce the SetPoint System in targeted US cities this year, followed by expansion across the country starting in early 2026.' SetPoint Medical is also exploring the use of its neuroimmune modulation platform for other autoimmune diseases such as multiple sclerosis (MS) and Crohn's disease. In March 2024, the company's neuroimmune modulation device secured a breakthrough device designation to treat relapsing-remitting MS. "FDA approves SetPoint's neuroimmune modulation device for RA treatment" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
34 minutes ago
- Yahoo
After my mum died of dementia I knew I had to change my life to save my brain
Having watched my beautiful, witty and highly intelligent mum bravely battle dementia for 10 years I know I would do anything to prevent the same happening to me – and to save my family from having to stand by and witness it. Could a brain coach help? One two-year clinical trial found that it increased cognitive function by 74 per cent after two years. Dementia prevention coach Susan Saunders, who trained with US neuroscientist Dr Dale Bredesen, runs a three-month long Better Brain Framework that promises improved memory, sharper cognition and to banish brain fog. When I approach her about doing the programme, she was very clear that it was all or nothing: I had to commit fully to her – a commitment that included six 40-minute Zoom coaching sessions, plus homework of six teaching videos. I was daunted but realised it had to be done. At the age of 59 I knew I had to change my life to save my brain. At our first meeting, Saunders, who is also a trained habit coach, told me that although she could not prevent dementia, what she could do was 'build long-term habits scientifically shown to reduce dementia risk'. Like me, Saunders lost her mother to dementia – in her case, Alzheimer's, in mine, a form of Parkinson's dementia. My mum, Anita, was the perfect storm. She had a mind like a steel trap and lived an intellectually stimulating life – she was an academic and a journalist, she had a PhD in English literature, she saw every Royal Shakespeare Company production, she read and wrote constantly. She was active and slim with a wide circle of friends and a happy marriage to her second husband who she met at 50. However, she lived in London near a busy road and had suffered a head injury in her 50s, falling down some stairs while sleepwalking. Then, when she was 65, she became a carer to her husband following a serious stroke that left him wheelchair-bound. She no longer rode her bike to the British Library every day, or went to the theatre. There was no time for reading. She began to decline and after five years was diagnosed with Parkinson's. Soon afterwards, the severe physical symptoms of her condition were joined by Parkinson's dementia, which features disturbed sleep, delusions, depression and anxiety. She died 10 years later, aged 81. Lifestyle may not have caused my mother's illness but it almost certainly hastened it. How we live matters. 'It's about building the life that puts your brain health first,' says Saunders. 'There's no magic pill coming any time soon to prevent dementia. The best hope we have is lifestyle changes.' What's more, work done now will give better memory, cognition and mental health now. 'Create an identity for yourself as someone who puts their brain first, prioritising yourself and your brain even above families, bosses, co-workers,' says Saunders. Not easy, she concedes, but vital. Over the next three months, I give it a try. Session one: nutrition for a better brain In our first session, Saunders reminds me that 20 per cent of everything we consume goes straight to our brain. 'Feed it c--p – it's going to work like c--p!' she summarises, pithily. Saunders's top tip on how to build a meal that's better for your brain is 'plan veg first'. This is because they 'give us a type of antioxidant, called polyphenols, which feed our brain. The first studies to focus on this found that people eating at least three portions of veg each day had slower rates of cognitive decline, and similar research showed green leafy veg also slowed cognitive decline. You're aiming for six to nine portions of veg a day.' I start planning our dinner plates veg first, then protein, then carbs. It's a revelation. We're having four veg (corn, grated carrots, avocados, beans) as well as our daily dose of broccoli. Protein (chicken, beef, fish) takes a quarter of the plate and in my case there's barely room for carbs, though the children and my husband still have pasta or potatoes. I replace my morning porridge with banana and yogurt, nuts and seeds for more protein, which Saunders also recommends. I succeed in 'crowding out' biscuits – snacking on nuts which provide healthy fats and in the afternoon I eat dried apricots or dates – yes, high in sugar but not processed, and full of fibre. I have to think long and hard about alcohol. The truth is, although I rarely get drunk, I drink a glass or two of wine most nights of the week. I rely on alcohol to manage stress and also to give me a feeling of being rewarded for working hard. Saunders' advice is to cut back. 'It's a neurotoxin. You know that feeling when you relax, then feel a bit woozy, then drunk. That's the impact on your brain.' I tell Saunders that when I did Dry January I felt great and she asks: 'What else could provide a different punctuation point at the end of the day? Can you start to move towards embodying someone who puts their brain first, who understands that alcohol is a neurotoxin and who needs less of it in their lives?' I stop buying wine at the supermarket on weeknights and start trying to limit wine to two evenings a week. I manage three. I am genuinely shocked at the difference it makes to the way I feel the next day. The less I drink, though, the worse I feel when I do drink – which also gives me pause for thought. Have I just got used to feeling under-par most of the time? Session two: movement, the brain's silver bullet 'Of all of the strategies we can try to reduce our dementia risk, none has more supporting scientific evidence than exercise,' Saunders tells me in our next session. It makes me sit up and listen. She explains that we're actually growing our brains when we exercise and that research has linked regular exercise to a 35 per cent lower risk of dementia. And it's not just structured exercise that makes a difference: moving about, for example doing regular housework, also has significant benefits. I'm not keen to start doing more domestic chores but I do take note. When it comes to exercise I am very faddy. One month I'm walking, the next week cycling, the next week doing weights. I've kept up swimming in cold water for 10 years now and although that's good, it's not enough. So, I start running up a huge hill near my house which is a form of resistance exercise (running counts, sort of) and getting enormously out of breath. All of these are vital for the brain. The running feels awful at first but the improvements are quick and when I get home I feel amazing. Added to the reduced drinking I'm as sharp as a pin and, my husband reports, a lot less grumpy than I used to be. Session three: A good night's sleep starts in the morning Saunders says: 'Deep sleep becomes harder to achieve as we get older but it's in this phase of sleep where the magic happens in terms of brain health. One study found that a 1 per cent reduction in deep sleep in people over 60 could lead to an increased dementia risk of 27 per cent.' That sounds pretty scary. Having been an insomniac in the past, however, I already have quite good sleep habits. I keep a regular bedtime and getting-up time and I pop a magnesium tablet (also recommended by Saunders) before bed. To this I now add 'morning light' with my uphill runs, which is good for the body's circadian rhythm. I am also keeping up the restraint around alcohol to see if this makes a difference. After a few nights of tossing and turning without a drink to clunk me on the head and get me to sleep I have started to drop off quickly and sleep deeply, waking earlier and much more refreshed. I love wine, and I couldn't bear the thought of life without a single vice, but I realise I've got to cut back further. When, a month in to the programme, I tell Saunders about my increasing clarity – the less I drink the sharper I feel – she gets excited: 'That's it working!' she says. 'That's better brain health.' She is right. Session four: stress is bad for the brain Stress has been linked to an increased risk of Alzheimer's in multiple studies. Allow time in your schedule to care for yourself. And that doesn't mean bubble baths. When I feel I'm getting stressed, I stop and tell myself how bad it is for my brain. I try to work through the suggestions Saunders has made: I distance myself from my feelings. I ask myself why am I feeling like this and what can I do. Most of all I remain aware when it's ramping up. As a result I feel less stressed, more in control and clearer headed. Session five: start dancing to boost cognitive engagement I feel cognitively engaged – I work as a journalist talking to interesting people, I have a chatty husband and three children, all lively, entertaining young people, I read as much as I can before falling asleep. But there's always more you could be doing. For me, table tennis and padel are out, as I am simply atrocious at sports, but Saunders has another suggestion. She says: 'It's been suggested that the best way to recreate the complex interaction of physical movement, memory, decision-making and social interaction that our ancestors experienced on that savannah is to dance.' This makes a lot of sense – it requires the full spectrum of cognitive skills, complex motor, perceptual and conceptual skills. One study examined the leisure activities of a group of older people over several decades and found that dancing provided the greatest dementia risk reduction (76 per cent) of any activity studied, cognitive or physical. I realise music is missing from my life, as I barely know how to listen to it any more – the tech is too complicated – and rely on occasional bursts from the radio in the car. I brace myself and log on to Spotify which leads to dancing in the kitchen until I am caught by a horrified teenager. It makes me realise there's always more you can add and that the danger point will come when one starts to work less. Plus my husband and I will need a plan for retirement (if that time ever comes) as we plan to move to the country – we will need to find new hobbies and interests. Session six: managing my environment The news about environmental factors leaves me downhearted. There are several categories of 'dementogens' including heavy metals, chemicals such as pesticides and cleaning products, and biotoxins such as moulds. However it is the air pollution that concerns me. Like my mum before me I live in London, in zone two, and I can't really get away from it. Nevertheless I change my run to the park so I go through back streets instead of on the road. I try not to breathe too much through my mouth (easier said than done when you're running uphill). Elsewhere I stop microwaving in plastic and consider not storing food in plastic, although given my immense Tupperware collection this will be a stretch. In the fullness of time I plan to replace some cleaning products. The other factor grouped together with this is loneliness, known to increase the risk of dementia. Research published in 2023 found that the risk of developing dementia over nine years was 27 per cent higher among socially isolated older adults, compared with older adults who were not socially isolated. Other research has found that those with a strong support system are 46 per cent less likely to develop dementia. 'The best workout we can give our brains is talking to a stranger,' says Saunders. 'The brain has to process so much at this precise moment – who is this person? What do they want from me? Am I safe? Talking to a stranger every day is a great way to flex cognitive engagement.' I talk to strangers all the time anyway, much to the mortification of my husband and children. I'll keep it up. The final result After three months I am convinced that we could all benefit from following this programme. For me, the two most significant and dramatic changes have been cutting alcohol back to once a week and starting running again. The combination of these two things plus the better sleep I get as a result has given me better clarity than I had at the age of 30 when I was starting out in journalism, living the high life in London, drinking, staying up late, stressing out, keeping irregular sleep patterns – you name it, I was doing it, wrong. The exhaustion of being a working parent and later also a carer for my mother, and the stress-related drinking that went along with it, didn't help in the years that followed. Most people following her programme have one such realisation says Saunders – whether it's exercising, better nutrition, self-care or simply taking time for themselves. I'm delighted that the effects are instant. Most importantly, if I stay on this path I will reduce my risk in the future. If only my mum could have done the same – though events conspired against her. I urge anyone who has become a carer, or whose parent has become a carer, to bear this in mind. I'm grateful to Saunders for opening my eyes and encouraging me with her three-month programme. Her advice is so simple and sane: 'It's so easy. Choose those things you can keep up. There's no magic pill to reduce dementia risk. It's about long term consistency. That's the closest thing we've got to a magic bullet.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.